Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori

Vincenzo Savarino, Daniela Tracci, Pietro Dulbecco, Maria Raffaella Mele, Patrizia Zentilin, Carlo Mansi, Sergio Vigneri

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: In analogy with proton pump inhibitors, H2-antagonists may also be responsible for false-negative results on urea breath test for the detection of Helicobacter pylori. In this study we assessed the frequency and duration of false-negative urea breath tests in patients given different doses of ranitidine. METHODS: A total of 120 consecutive dyspeptic patients infected with H. pylori on the basis of concomitant positive results of CLO-test, histology and urea breath test were recruited for this prospective, open, parallel-group study performed in an urban university gastroenterological clinic. They were randomized to receive an acute treatment with either ranitidine 300 mg once a day in the evening, ranitidine 300 mg once a day in the morning, ranitidine 150 mg b.i.d., or ranitidine 300 mg b.i.d. for 14 days. The urea breath test was performed on day 14 while patients were still taking ranitidine, and on day 21, 1 wk after completion of therapy. The test was repeated on day 28 in those patients who were still negative on day 21. Duplicate breath samples were collected after ingestion of 75 mg 13C-urea plus citric acid. A δ value >5‰ was considered positive. RESULTS: Of 118 patients infected with H. pylori, 15 (13%) had a negative urea breath test on day 14. The false-negative results were equally distributed among the four groups of ranitidine dosage. Nine of these patients reverted to positive at 7 days and the remaining six at 14 days after completion of therapy. CONCLUSIONS: Our study shows that ranitidine negatively affects the results of urea breath testing, independent of the given dosage. Patients undergoing this examination for H. pylori diagnosis should discontinue use of H2-antagonists 2 wk before testing.

Original languageEnglish
Pages (from-to)348-352
Number of pages5
JournalAmerican Journal of Gastroenterology
Volume96
Issue number2
DOIs
Publication statusPublished - 2001

Fingerprint

Breath Tests
Ranitidine
Helicobacter pylori
Urea
Proton Pump Inhibitors
Citric Acid
Histology
Therapeutics
Eating

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori. / Savarino, Vincenzo; Tracci, Daniela; Dulbecco, Pietro; Mele, Maria Raffaella; Zentilin, Patrizia; Mansi, Carlo; Vigneri, Sergio.

In: American Journal of Gastroenterology, Vol. 96, No. 2, 2001, p. 348-352.

Research output: Contribution to journalArticle

Savarino, Vincenzo ; Tracci, Daniela ; Dulbecco, Pietro ; Mele, Maria Raffaella ; Zentilin, Patrizia ; Mansi, Carlo ; Vigneri, Sergio. / Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori. In: American Journal of Gastroenterology. 2001 ; Vol. 96, No. 2. pp. 348-352.
@article{c56c33ddad6647b3a40aa0c5214dc906,
title = "Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori",
abstract = "OBJECTIVES: In analogy with proton pump inhibitors, H2-antagonists may also be responsible for false-negative results on urea breath test for the detection of Helicobacter pylori. In this study we assessed the frequency and duration of false-negative urea breath tests in patients given different doses of ranitidine. METHODS: A total of 120 consecutive dyspeptic patients infected with H. pylori on the basis of concomitant positive results of CLO-test, histology and urea breath test were recruited for this prospective, open, parallel-group study performed in an urban university gastroenterological clinic. They were randomized to receive an acute treatment with either ranitidine 300 mg once a day in the evening, ranitidine 300 mg once a day in the morning, ranitidine 150 mg b.i.d., or ranitidine 300 mg b.i.d. for 14 days. The urea breath test was performed on day 14 while patients were still taking ranitidine, and on day 21, 1 wk after completion of therapy. The test was repeated on day 28 in those patients who were still negative on day 21. Duplicate breath samples were collected after ingestion of 75 mg 13C-urea plus citric acid. A δ value >5‰ was considered positive. RESULTS: Of 118 patients infected with H. pylori, 15 (13{\%}) had a negative urea breath test on day 14. The false-negative results were equally distributed among the four groups of ranitidine dosage. Nine of these patients reverted to positive at 7 days and the remaining six at 14 days after completion of therapy. CONCLUSIONS: Our study shows that ranitidine negatively affects the results of urea breath testing, independent of the given dosage. Patients undergoing this examination for H. pylori diagnosis should discontinue use of H2-antagonists 2 wk before testing.",
author = "Vincenzo Savarino and Daniela Tracci and Pietro Dulbecco and Mele, {Maria Raffaella} and Patrizia Zentilin and Carlo Mansi and Sergio Vigneri",
year = "2001",
doi = "10.1016/S0002-9270(00)02310-8",
language = "English",
volume = "96",
pages = "348--352",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori

AU - Savarino, Vincenzo

AU - Tracci, Daniela

AU - Dulbecco, Pietro

AU - Mele, Maria Raffaella

AU - Zentilin, Patrizia

AU - Mansi, Carlo

AU - Vigneri, Sergio

PY - 2001

Y1 - 2001

N2 - OBJECTIVES: In analogy with proton pump inhibitors, H2-antagonists may also be responsible for false-negative results on urea breath test for the detection of Helicobacter pylori. In this study we assessed the frequency and duration of false-negative urea breath tests in patients given different doses of ranitidine. METHODS: A total of 120 consecutive dyspeptic patients infected with H. pylori on the basis of concomitant positive results of CLO-test, histology and urea breath test were recruited for this prospective, open, parallel-group study performed in an urban university gastroenterological clinic. They were randomized to receive an acute treatment with either ranitidine 300 mg once a day in the evening, ranitidine 300 mg once a day in the morning, ranitidine 150 mg b.i.d., or ranitidine 300 mg b.i.d. for 14 days. The urea breath test was performed on day 14 while patients were still taking ranitidine, and on day 21, 1 wk after completion of therapy. The test was repeated on day 28 in those patients who were still negative on day 21. Duplicate breath samples were collected after ingestion of 75 mg 13C-urea plus citric acid. A δ value >5‰ was considered positive. RESULTS: Of 118 patients infected with H. pylori, 15 (13%) had a negative urea breath test on day 14. The false-negative results were equally distributed among the four groups of ranitidine dosage. Nine of these patients reverted to positive at 7 days and the remaining six at 14 days after completion of therapy. CONCLUSIONS: Our study shows that ranitidine negatively affects the results of urea breath testing, independent of the given dosage. Patients undergoing this examination for H. pylori diagnosis should discontinue use of H2-antagonists 2 wk before testing.

AB - OBJECTIVES: In analogy with proton pump inhibitors, H2-antagonists may also be responsible for false-negative results on urea breath test for the detection of Helicobacter pylori. In this study we assessed the frequency and duration of false-negative urea breath tests in patients given different doses of ranitidine. METHODS: A total of 120 consecutive dyspeptic patients infected with H. pylori on the basis of concomitant positive results of CLO-test, histology and urea breath test were recruited for this prospective, open, parallel-group study performed in an urban university gastroenterological clinic. They were randomized to receive an acute treatment with either ranitidine 300 mg once a day in the evening, ranitidine 300 mg once a day in the morning, ranitidine 150 mg b.i.d., or ranitidine 300 mg b.i.d. for 14 days. The urea breath test was performed on day 14 while patients were still taking ranitidine, and on day 21, 1 wk after completion of therapy. The test was repeated on day 28 in those patients who were still negative on day 21. Duplicate breath samples were collected after ingestion of 75 mg 13C-urea plus citric acid. A δ value >5‰ was considered positive. RESULTS: Of 118 patients infected with H. pylori, 15 (13%) had a negative urea breath test on day 14. The false-negative results were equally distributed among the four groups of ranitidine dosage. Nine of these patients reverted to positive at 7 days and the remaining six at 14 days after completion of therapy. CONCLUSIONS: Our study shows that ranitidine negatively affects the results of urea breath testing, independent of the given dosage. Patients undergoing this examination for H. pylori diagnosis should discontinue use of H2-antagonists 2 wk before testing.

UR - http://www.scopus.com/inward/record.url?scp=0035126992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035126992&partnerID=8YFLogxK

U2 - 10.1016/S0002-9270(00)02310-8

DO - 10.1016/S0002-9270(00)02310-8

M3 - Article

C2 - 11232674

AN - SCOPUS:0035126992

VL - 96

SP - 348

EP - 352

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 2

ER -